Enhanced therapeutic efficacy of sequential ¹⁷⁷Lu/²²⁵Ac-LNC1004 FAP-targeted radionuclide therapy combined with anti-PD-L1 blockade in pancreatic cancer.
APA
Shi M, Liu J, et al. (2026). Enhanced therapeutic efficacy of sequential ¹⁷⁷Lu/²²⁵Ac-LNC1004 FAP-targeted radionuclide therapy combined with anti-PD-L1 blockade in pancreatic cancer.. European journal of nuclear medicine and molecular imaging. https://doi.org/10.1007/s00259-026-07878-3
MLA
Shi M, et al.. "Enhanced therapeutic efficacy of sequential ¹⁷⁷Lu/²²⁵Ac-LNC1004 FAP-targeted radionuclide therapy combined with anti-PD-L1 blockade in pancreatic cancer.." European journal of nuclear medicine and molecular imaging, 2026.
PMID
41973229
같은 제1저자의 인용 많은 논문 (5)
- Celastrol inhibits the immune escape and proliferation of triple - negative breast cancer (TNBC) through the LKB1 - AMPK - PD-L1/MYC signaling pathway.
- Transcriptomic landscape of transposable elements reveals - as a potential oncogene and therapeutic target in pancreatic adenocarcinoma.
- Accelerating discovery of cancer causes for prevention in the era of rising early-onset cancers.
- Latent profile analysis of uncertainty in illness and eating self-efficacy in patients with gastric cancer and its associated factors: a cross-sectional study.
- New progress in hydrogen-synergistic diagnostic and therapeutic nanoplatforms for tumor treatment.